Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Min Ko

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Iscience|June 15, 2026
The lysophosphatidylcholine-HIF-1α axis enhances apolipoprotein E sialylation and promotes electronegative LDL accumulationHua-Chen Chan, Hsiu-Chuan Chan, Liu-Fang Wang, et al.
Medicine|July 12, 2016
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapyChung-Feng Huang, Ming-Lun Yeh, Cing-Yi Huang, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2017
25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacyJee-Fu Huang, Yu-Min Ko, Chung-Feng Huang, et al.
Journal of Gastroenterology and Hepatology|August 3, 2019
Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevirChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Ebiomedicine|March 11, 2017
Corrigendum to "Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment" [EBioMedicine 15 (2017) 81-89]Chung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, et al.
Oncotarget|April 22, 2017
Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis CChung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, et al.
Ebiomedicine|December 22, 2016
Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral TreatmentChung-Feng Huang, Cing-Yi Huang, Ming-Lun Yeh, et al.
Journal of Gastroenterology and Hepatology|February 24, 2017
Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antiviralsMing-Lun Yeh, Chung-Feng Huang, Meng-Hsuan Hsieh, et al.
Journal of Gastroenterology and Hepatology|July 24, 2025
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis BTyng-Yuan Jang, Chih-Wen Wang, Po-Cheng Liang, et al.
Medicine|June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and databasePei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Iscience|June 15, 2026
The lysophosphatidylcholine-HIF-1α axis enhances apolipoprotein E sialylation and promotes electronegative LDL accumulationHua-Chen Chan, Hsiu-Chuan Chan, Liu-Fang Wang, et al.
Medicine|July 12, 2016
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapyChung-Feng Huang, Ming-Lun Yeh, Cing-Yi Huang, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2017
25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacyJee-Fu Huang, Yu-Min Ko, Chung-Feng Huang, et al.
Journal of Gastroenterology and Hepatology|August 3, 2019
Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevirChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Ebiomedicine|March 11, 2017
Corrigendum to "Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment" [EBioMedicine 15 (2017) 81-89]Chung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, et al.
Oncotarget|April 22, 2017
Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis CChung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, et al.
Ebiomedicine|December 22, 2016
Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral TreatmentChung-Feng Huang, Cing-Yi Huang, Ming-Lun Yeh, et al.
Journal of Gastroenterology and Hepatology|February 24, 2017
Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antiviralsMing-Lun Yeh, Chung-Feng Huang, Meng-Hsuan Hsieh, et al.
Journal of Gastroenterology and Hepatology|July 24, 2025
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis BTyng-Yuan Jang, Chih-Wen Wang, Po-Cheng Liang, et al.
Medicine|June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and databasePei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.
Pageof 4